| 318 | 0 | 144 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 评价苓桂术甘汤质量。方法 分析采用BP C18 Plus色谱柱(250 mm×4.6 mm, 5μm);流动相0.1%磷酸-乙腈,梯度洗脱;体积流量0.8 mL/min;柱温30℃;检测波长220 nm。建立基准样品、现代制剂、传统高压锅代煎样品、智能代煎样品(各3批)HPLC指纹图谱。以甘草苷为内标,计算芹糖甘草苷、肉桂酸、桂皮醛、甘草酸、白术内酯Ⅲ、白术内酯Ⅱ相对校正因子,一测多评法测定其含量。再进行主成分分析、聚类分析。结果 12批样品指纹图谱中有26个共有峰,相似度均大于0.95,其中智能代煎样品与基准样品的相似度最高。7种成分在各自范围内线性关系良好(r≥0.999 6),平均加样回收率90.72%~104.16%,RSD 0.48%~6.11%,一测多评法所得结果与外标法接近。各批样品聚为2类,现代制剂、智能代煎样品对基准样品的还原度较高。结论 该方法稳定可靠,可用于苓桂术甘汤各用药形式的质量控制,其智能代煎样品可最大程度还原基准样品的物质基础分布。
Abstract:AIM To evaluate the quality of Linggui Zhugan Decoction.METHODS The analysis was performed on a 30 ℃ thermostatic BP C18 Plus column(250 mm×4.6 mm, 5 μm), with the mobile phase comprising of 0.1%phosphoric acid-acetonitrile flowing at 0.8 mL/min in a gradient elution manner, and the detection wavelength was set at 220 nm. The HPLC fingerprints for reference samples, modern preparations, traditional pressure cooker-decocting samples and intelligent decocting samples(3 batches each) were established. Liquiritin was used as an internal standard to calculate the relative correction factors of liquiritin apioside, cinnamic acid, cinnamaldehyde, glycyrrhizic acid, atractylenolide Ⅲ and atractylenolide Ⅱ, after which the content determination was made by quantitative analysis of multi-components by single-marker(QAMS). Subsequently, principal component analysis and cluster analysis were performed.RESULTS There were 26 common peaks in the fingerprints for 12 batches of samples with the similarities of more than 0.95, among which the intelligent decocting samples demonstrated the highest similarity to the reference samples. Seven constituents showed good linear relationships within their own ranges(r≥0.999 6), whose average recoveries were 90.72%-104.16%with the RSDs of 0.48%-6.11%. The result obtained by QAMS approximated those obtained by external standard method. Various batches of samples were clustered into 2 types, the modern preparations and intelligent decocting samples exhibited high reducibilities to reference samples.CONCLUSION This stable and reliable method can be used for the quality control of various dosage forms of Linggui Zhugan Decoction, whose intelligent decocting samples can preserve the material composition of reference samples to the greatest extent.
[1] 李月,高敏洁,高静.基于政策梳理的古代经典名方中药复方制剂转化探讨[J].上海医药,2023,44(13):16-20.
[2] 宋菊,阳长明,于江泳,等.古代经典名方中药复方制剂的转化研究与审评决策思路[J].中药药理与临床,2024,40(3):2-7.
[3] 曾瑾,陈平,刘阳,等.中药复方制剂质量控制与评价的监管科学[J].中药药理与临床,2024,40(2):17-22.
[4] 王锦轩,姚霞,李耿.基于化学特征的中药鉴定技术进展及趋势[J].中国中药杂志,2024,49(17):4617-4629.
[5] Luo Y D,Yang H B,Tao G C.Systematic review on fingerprinting development to determine adulteration of Chinese herbal medicines[J].Phytomedicine,2024,129:155667.
[6] 连益纯,林静,李知瑾,等.HPLC特征图谱技术在中药制剂质量控制中的应用进展[J].海峡药学,2024,36(2):1-5.
[7] 梁生旺,张彤.中药分析学[M].北京:中国中医药出版社,2021:127.
[8] 方宝霞,李湘,滚代芬,等.一测多评法应用于化学药及中药的化学药成分质量控制研究进展[J].药物评价研究,2023,46(6):1382-1388.
[9] 国家中医药管理局,国家药品监督管理局.古代经典名方目录(第一批)[Z].2018-04-13.
[10] 李玲,季光,张彤,等.经典名方苓桂术甘汤复方制剂的研制[J].中成药,2023,45(10):3165-3172.
[11] 张晟安,刘志栋,戴亮,等.苓桂术甘汤的临床应用:1项系统性评价与Meta分析[J].中草药,2023,54(14):4599-4614.
[12] Lv J Y,Fu Z Y,Wang Y X,et al.Lingguizhugan decoction ameliorates renal injury secondary to heart failure by improving pyroptosis through TLR4/NF-KB/IRE1α pathway[J].Phytomedicine,2025,2025,143:156862.
[13] Chen X,Huang W X,Lü H M,et al.Identification of Cald1 as a novel regulator of Linggui Zhugan decoction for improving insulin resistance in vivo and in vitro[J].J Tradit Chin Med,2021,41(5):706-716.
[14] Chen X,Tian Q,Gao M,et al.Lingguizhugan decoction enhances autophagy of Alzheimer’s disease via regulating the mTOR/ p70s6K pathway in vivo and in vitro[J].Front Aging Neurosci,2025,17:1478199.
[15] Ma H M,Guo L,Chen Y,et al.Linggui Zhugan Decoction for peripheral vertigo:A protocol for systematic review and meta-analysis[J].Medicine (Baltimore),2021,100(16):e25563.
[16] China Association of Chinese Medicine.Top 10 academic progress on traditional Chinese medicine in 2022[J].Sci Tradit Chin Med,2023,1(2):73-89.
[17] 顾思浩.经典名方苓桂术甘汤物质基准与复方制剂研究[D].上海:上海中医药大学,2020.
[18] Li L,Wang N,Fan X L,et al.A preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and its anti-gastric ulcer effect[J].Saudi Pharm J,2023,31(12):101833.
[19] Chen L P,Zhang L F,Liu S,et al.Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota[J].Microbiol Spectr,2024,12(6):e0197923.
[20] 罗珊.苓桂术甘汤药效物质基础及质量控制方法研究[D].杭州:浙江大学,2020.
[21] 廖正根,李龚龙,温佳豪,等.基于质量源于设计理念与基准关联度的经典名方苓桂术甘汤的提取工艺研究[J].江西中医药,2024,55(7):64-69.
[22] 闵会,徐斌,郑亚纯,等.经典名方苓桂术甘汤物质基准质量控制标准研究[J].中国药品标准,2022,23(6):587-595.
[23] Li S Y,Gao Y T,Wang X,et al.Qualitative and quantitative studies on chemical constituents of Ling-gui-zhu-gan decoction:In vitro and in vivo[J].J Sep Sci,2023,46(19):e2300465.
[24] Li S Y,Sun Y F,Gao Y T,et al.Spectrum-effect relationship analysis based on HPLC-FT-ICR-MS and multivariate statistical analysis to reveal the pharmacodynamic substances of Ling-Gui-Zhu-Gan decoction on Alzheimer’s disease[J].J Pharm Biomed Anal,2024,237:115765.
[25] 上海中医药大学.一种茯苓水溶性成分的分离鉴定方法及其在含茯苓复方中的应用:中国,CN202410950055.2[P],2024-11-29.
基本信息:
中图分类号:R286.0
引用信息:
[1]林学玉,丁子涵,周嘉浩,等.基于HPLC指纹图谱及一测多评法评价苓桂术甘汤质量[J].中成药,2026,48(01):1-9.
基金信息:
国家重点研发计划项目(2022YFC3501705); 国家自然科学基金面上项目(82274066); 上海市领军人才计划(SHLJ2019100); 上海中医药大学第十七批大学生创新创业活动计划(2023SHUTCM100)
2026-01-20
2026-01-20